Literature DB >> 12217277

[Abuse, tolerance and dependence of zolpidem: three case reports].

J Correas Lauffer1, D Braquehais Conesa, E Barbudo Del Cura, E Ochoa Mangada.   

Abstract

Zolpidem is an imidazopyridine, which acts at the benzodiacepine omega1 receptor subtype. Zolpidem was marketed as a short-acting hypnotic and it was assumed that had a lower potential for abuse than benzodiacepines. Since 1993, several cases of zolpidem dependence have been reported. We have observed three patients with abuse, dependence and withdrawal syndrome to zolpidem. Two of them had history of drugs abuse and all of them developed withdrawal symptoms when discontinuing it. In Spain, zolpidem may be sold without medical prescription like other non benzodiacepines hypnotics and it may be playing an important role in the increase of abuse cases. We think zolpidem should be considered as a benzodiacepine with the same control and regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217277

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  2 in total

Review 1.  Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.

Authors:  Caroline Victorri-Vigneau; Eric Dailly; Gwenaëlle Veyrac; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

2.  Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs.

Authors:  Miguel Angel Fernández García; Antonio Olry de Labry Lima; Ingrid Ferrer Lopez; Clara Bermúdez-Tamayo
Journal:  J Pharm Policy Pract       Date:  2018-01-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.